Details

Autor(en) / Beteiligte

• Chan, Raymond H
• Maron, Barry
• olivotto, iacopo
• Assenza, Gabriele
• Hong, M. Susie
• Lesser, John
• Haas, Tammy
• Gruner, Christiane
• Crean, Andrew
• Rakowski, Harry
• Udelson, James
• Rowin, Ethan
• Tomberli, Benedetta
• Spirito, Paolo
• Formisano, Francesco
• Biagini, Elena
• Rapezzi, Claudio
• De Cecco, Carlo Nicola
• Autore, Camillo
• Cook, Earl Francis
• Hauser, Thomas
• Gibson, C. Michael
• Manning, Warren
• Appelbaum, Evan
• Maron, Martin

Titel

PROGNOSTIC UTILITY OF CONTRAST-ENHANCED CARDIOVASCULAR MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: AN INTERNATIONAL MULTICENTER STUDY

Ist Teil von

• Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E1570-E1570

Ort / Verlag

New York: Elsevier Inc

Erscheinungsjahr

2012

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• There was no statistically significant relationship between presence of LGE and a number of clinical end-points including all HCM-related adverse disease events (OR 1.64, 95% CI 0.99-2.70, p>0.05), progression to NYHA class III or IV or death from heart failure or stroke (OR 1.42, 95%CI 0.78-2.51, p=0.24), or sudden death (OR 1.89, 95% CI 0.78-4.55, p=0.16).